CheckMan Stock Market Overview

Goldman (GS) intends to expand its lending services to private equity and asset managers, capitalizing on a potentially thriving market driven by increased fundraising.

Gilead Sciences (GILD) experimental candidate, seladelpar, demonstrates significant improvements in liver disease progression and reduced itching in primary biliary cholangitis study.

Boston Scientific (BSX) mCRM System is designed to communicate wirelessly and coordinate painless intracardiac anti-tachycardia pacing (ATP) therapy.

This new plant will be AstraZeneca's (AZN) first manufacturing facility for producing novel antibody drug conjugates from start to finish. It is scheduled to open in 2029.

CyberArk plans to acquire Venafi from Thoma Bravo for an enterprise value of about $1.54 billion, saying it aims to create a unified platform for machine identity security at scale. The acquisition will add Venafi's machine identity management solutions to CyberArk's identity security capabilities, the companies said in a Monday (May 20) press release.

The company markets its products under these brand names: GUESS GUESS?

ALERT: Take This Retirement Quiz Now  (Sponsored) Take the quiz below to get matched with a financial advisor today.

Tyson Foods' (TSN) iconic brands continue to resonate with consumers, contributing to market share growth. The company's growth strategy is based on three main pillars.

The TJX Companies' (TJX) fiscal first-quarter performance is likely to reflect gains from the robust Marmaxx division. Strong momentum in its HomeGoods is working well.

Wynn Resorts (WYNN) focus on non-gaming business and strategic expansion plans bode well. However, increased operating expenses are a concern.